fziomed
-
Spine
FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO
New CEO Paul Mraz also joins FzioMed Inc.’s Board of Directors; Company set to accelerate growth of market leading Oxiplex®…
Read More » -
Spine
FzioMed Enrolls Patient Number Fifty in Clinical Study to Support the Effectiveness and Safety of Oxiplex® for the Reduction of Pain and Symptoms Following Lumbar Surgery
SAN LUIS OBISPO, Calif., March 28, 2019 /PRNewswire/ — Oxiplex® is an absorbable, synthetic viscoelastic gel that is applied following partial discectomy,…
Read More » -
Biologics
FzioMed Announces 500,000 Units of Oxiplex® Shipped Worldwide
January 10, 2018 SAN LUIS OBISPO, Calif.–(BUSINESS WIRE)–FzioMed, Inc. a leading biomaterials company, is pleased to announce that Oxiplex sales…
Read More » -
Hospitals
FzioMed Receives FDA Approval for Small Confirmatory Study of Oxiplex® in Patients Undergoing Lumbar Surgery for Disc Herniation
October 23, 2017 SAN LUIS OBISPO, Calif.–(BUSINESS WIRE)–FzioMed, Inc., a biomaterials company celebrating 21 years in business, has received approval…
Read More » -
Financial
FzioMed Announces Sale of 400,000th Unit of Oxiplex
SAN LUIS OBISPO, Calif.–(BUSINESS WIRE)–FzioMed, Inc. (www.fziomed.com) announced that it has shipped the 400,000th unit of Oxiplex® gel. Oxiplex is approved outside…
Read More » -
FzioMed Announces Date for Medical Device Dispute Resolution Panel on Oxiplex®
SAN LUIS OBISPO, Calif.–(BUSINESS WIRE)–FzioMed, Inc., a medical device manufacturer specializing in biomaterials, has received notification from FDA that the…
Read More »